PPLPHARMA — Piramal Pharma Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹254.61bn
- IN₹297.41bn
- IN₹91.51bn
Annual cashflow statement for Piramal Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | R2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 3,491 | 4,410 | -1,675 | 1,198 | 3,417 |
| Depreciation | |||||
| Non-Cash Items | -520 | 2,009 | 4,588 | 5,353 | 5,563 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -3,234 | -3,850 | -4,841 | -3,911 | -8,221 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 347 | 8,432 | 4,839 | 10,045 | 8,923 |
| Capital Expenditures | -581 | -8,895 | -9,648 | -7,120 | -6,644 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -43,248 | -9,226 | -3,740 | 2,780 | 1,869 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -43,829 | -18,121 | -13,388 | -4,340 | -4,775 |
| Financing Cash Flow Items | 8,816 | -1,445 | -2,781 | -4,837 | -4,474 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 44,942 | 7,942 | 8,178 | -4,224 | -4,408 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1,460 | -1,768 | -320 | 1,660 | -369 |